Brexit deal and Covid vaccines ‘to deliver £145billion boost to London stock markets’
- Businesses have greeted Boris Johnson’s agreement with the EU with relief
- The deal was a ‘double dose of good news’ for the country along with vaccines
- Analysts had been predicting a crash in shares if a No Deal had happened
Analysts at financial data giant Bloomberg said the deal was a ‘double dose of good news’ for the country as excitement also swept the market over the anticipation that vaccines would begin to turn the tide against Covid.
Pension funds and investors on the London stock market are expecting a £145 billion boost following the Brexit accord, according to a top City firm
The analysts said the markets may remain subdued for the first six months of next year until the pandemic receded, but the value of shares listed on the FTSE should increase eight per cent during 2022 as markets gain fresh confidence.
Businesses and financial markets experts greeted Boris Johnson’s agreement with the European Union with relief. EU Chief Negotiator Michel Barnier is pictured
The same analysts had been predicting a crash in shares if a No Deal had been declared, even with a pandemic recovery.
Economist and Brexit advocate Gerard Lyons said: ‘The Brexit deal should be a positive for the UK.
‘The deal has also relieved a degree of uncertainty that impacted us for a period.’
Mr Lyons said the deal was ‘not just about leaving the EU – it’s about the policies we implement once we have left’.